Editas Medicine (NASDAQ:EDIT) First Quarter 2024 Results Key Financial Results Revenue: US$1.14m (down 89% from 1Q 2023). Net loss: US$62.0m (loss widened by 26% from 1Q 2023). US$0.76 loss per share...
Source LinkEditas Medicine (NASDAQ:EDIT) First Quarter 2024 Results Key Financial Results Revenue: US$1.14m (down 89% from 1Q 2023). Net loss: US$62.0m (loss widened by 26% from 1Q 2023). US$0.76 loss per share...
Source Link
Comments